US Physical Therapy (USPH) Stock Forecast & Price Target

Compare

102 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

USPH Analyst Ratings

Strong Buy

3 Buy

1 Hold

0 Sell

Based on 4 analysts giving stock ratings to

Physical Therapy

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

USPH Stock 12 Month Forecast

Average Price Target

$104.67

▲(23.71% Upside)

Based on 4 Wall Street analysts offering 12 month price targets for US Physical Therapy in the last 3 months. The average price target is $104.67 with a high forecast of $113.00 and a low forecast of $98.00. The average price target represents a 23.71% change from the last price of $84.61.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"68":"$68","91":"$91","114":"$114","79.5":"$79.5","102.5":"$102.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":113,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$113.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":104.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$104.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":98,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$98.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[68,79.5,91,102.5,114],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,69.61,72.94769230769231,76.28538461538461,79.62307692307692,82.96076923076923,86.29846153846154,89.63615384615385,92.97384615384615,96.31153846153846,99.64923076923077,102.98692307692308,106.32461538461538,109.66230769230769,{"y":113,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,69.61,72.30692307692307,75.00384615384615,77.70076923076923,80.39769230769231,83.09461538461538,85.79153846153847,88.48846153846154,91.18538461538462,93.88230769230769,96.57923076923078,99.27615384615385,101.97307692307692,{"y":104.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,69.61,71.79384615384615,73.97769230769231,76.16153846153846,78.34538461538462,80.52923076923076,82.71307692307693,84.89692307692307,87.08076923076923,89.26461538461538,91.44846153846154,93.63230769230769,95.81615384615384,{"y":98,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":93.82,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.73,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.18,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.6,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.68,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.2,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.2,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.64,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.56,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.55,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.79,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.18,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.61,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$113.00

Average Price Target$104.67

Lowest Price Target$98.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Rosa Clinessa

TR | OpenAI - 4o

$98

Buy

15.83%

Upside

Reiterated

08/14/25

AI Generated ArticleAI Generated Article

Michael Petusky

Barrington

$98→$103

Buy

21.74%

Upside

Reiterated

08/08/25

U.S. Physical Therapy price target raised to $103 from $98 at BarringtonU.S. Physical Therapy price target raised to $103 from $98 at Barrington

Ryan Daniels

William Blair

―

Hold

―

Reiterated

08/06/25

Balanced Outlook: U.S. Physical Therapy's Strong Earnings and Pricing Challenges Justify Hold Rating

Constantine Davides

Citizens JMP

$113

Buy

33.55%

Upside

Reiterated

07/25/25

Citizens JMP Sticks to Their Buy Rating for US Physical Therapy (USPH)Citizens JMP analyst Constantine Davides reiterated a Market Outperform rating and $113.00 price target on U.S. Physical Therapy (NYSE: USPH).

Brian Tanquilut

Jefferies

$110

Buy

30.01%

Upside

Reiterated

05/22/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Joanna Gajuk

Bank of America Securities

―

Buy

―

Reiterated

05/16/25

US Physical Therapy (USPH) Gets a Buy from Bank of America Securities

Lisa Gill

J.P. Morgan

$120→$110

Buy

30.01%

Upside

Reiterated

03/19/25

U.S. Physical Therapy price target lowered to $110 from $120 at JPMorganU.S. Physical Therapy price target lowered to $110 from $120 at JPMorgan

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Rosa Clinessa

TR | OpenAI - 4o

$98

Buy

15.83%

Upside

Reiterated

08/14/25

AI Generated ArticleAI Generated Article

Michael Petusky

Barrington

$98→$103

Buy

21.74%

Upside

Reiterated

08/08/25

U.S. Physical Therapy price target raised to $103 from $98 at BarringtonU.S. Physical Therapy price target raised to $103 from $98 at Barrington

Ryan Daniels

William Blair

―

Hold

―

Reiterated

08/06/25

Balanced Outlook: U.S. Physical Therapy's Strong Earnings and Pricing Challenges Justify Hold Rating

Constantine Davides

Citizens JMP

$113

Buy

33.55%

Upside

Reiterated

07/25/25

Brian Tanquilut

Jefferies

$110

Buy

30.01%

Upside

Reiterated

05/22/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Joanna Gajuk

Bank of America Securities

―

Buy

―

Reiterated

05/16/25

US Physical Therapy (USPH) Gets a Buy from Bank of America Securities

Lisa Gill

J.P. Morgan

$120→$110

Buy

30.01%

Upside

Reiterated

03/19/25

U.S. Physical Therapy price target lowered to $110 from $120 at JPMorganU.S. Physical Therapy price target lowered to $110 from $120 at JPMorgan

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering US Physical Therapy

1 Month

xxx

Success Rate

18/35 ratings generated profit

Average Return

-0.97%

reiterated a xxx

rating 21 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 51.43% of your transactions generating a profit, with an average return of -0.97% per trade.

3 Months

xxx

Success Rate

21/35 ratings generated profit

Average Return

+5.39%

reiterated a xxx

rating 21 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +5.39% per trade.

1 Year

Michael PetuskyBarrington

Success Rate

22/35 ratings generated profit

Average Return

+4.86%

reiterated a buy rating 21 days ago

Copying Michael Petusky's trades and holding each position for 1 Year would result in 62.86% of your transactions generating a profit, with an average return of +4.86% per trade.

2 Years

xxx

Success Rate

22/35 ratings generated profit

Average Return

+5.38%

reiterated a xxx

rating 21 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 62.86% of your transactions generating a profit, with an average return of +5.38% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

USPH Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, USPH has received 10 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. USPH average Analyst price target in the past 3 months is 104.67.

Each month's total comprises the sum of three months' worth of ratings.

USPH Financial Forecast

USPH Earnings Forecast

Next quarter’s earnings estimate for USPH is $0.67 with a range of $0.59 to $0.73. The previous quarter’s EPS was $0.81. USPH beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year USPH has Preformed in-line its overall industry.

USPH Sales Forecast

Next quarter’s sales forecast for USPH is $194.05M with a range of $192.10M to $195.80M. The previous quarter’s sales results were $197.34M. USPH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 71.43% of the time in the same period. In the last calendar year USPH has Preformed in-line its overall industry.

USPH Stock Forecast FAQ

What is USPH’s average 12-month price target, according to analysts?

Based on analyst ratings, U.s. Physical Therapy’s 12-month average price target is 104.67.

What is USPH’s upside potential, based on the analysts’ average price target?

U.s. Physical Therapy has 23.71% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is USPH a Buy, Sell or Hold?

U.s. Physical Therapy has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.

What is U.s. Physical Therapy’s price target?

The average price target for U.s. Physical Therapy is 104.67. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $113.00 ,the lowest forecast is $98.00. The average price target represents 23.71% Increase from the current price of $84.61.

What do analysts say about U.s. Physical Therapy?

U.s. Physical Therapy’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of USPH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

US Physical Therapy (USPH) Stock Forecast & Price Target

USPH Analyst Ratings

USPH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering US Physical Therapy

USPH Analyst Recommendation Trends

USPH Financial Forecast

USPH Earnings Forecast

USPH Sales Forecast

USPH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts